-
Most Recent
Search Results
240 results for JNY
Apple Stock Is a Sound Investment in Any Market
AAPL stock is a sound investment in any market condition. Nevertheless, investors would do well spread entry over time for solid returns.
Affirm Stock Is a Hot Buy on Any Dip
AFRM stock is a long-term buy, but there will likely be better entry points. Investors will do well with Affirm, but patience is required.
Wynn Resorts Stock Is a Buy on Any Dip
Wynn Resorts raised much-needed money this week, securing its future. That makes shares worth owning, but wait for a dip to get involved.
Dive Into Switchback Energy’s Stock on Any Pullback
The pending merger with ChargePoint could supercharge SBE stock, but tread carefully as “EV Mania” starts to cool.
5 REITs for Any Stock Market Conditions
REITs have been performing well so far in 2019, and if you pick the right ones they’ll likely keep performing for you long term.
4 Artificial Intelligence Stocks for Any Investor
You can get into a growing tech trend with these 4 artificial intelligence stocks. They reward investors in more than one way.
JNJ Stock Is Undervalued, but Not Compelling Given These Headwinds
JNJ stock is supported by strong fundamentals, but weak optics will keep a lid on shares for the foreseeable future.
Cronos Stock Will Not Rebound Any Time Soon
With the MORE Act unlikely to pass Congress, and supply issues still plaguing Canada, you can find better opportunities elsewhere.
BNY Mellon Announces Crypto Custody Services
BNY Mellon is the newest bank to jump into the crypto world, launching its Bitcoin and Ethereum custody service.
Make Money in Any Market with This Key Strategy
Making money in any market is actually simple.
The Best Strategy to Make Money in Any Market
Making money in any market is actually simple.
Johnson & Johnson (JNJ) a Sell at $129.79
Johnson & Johnson (JNJ) a Sell at $129.79 based on the most current SEC filings, and relative pricing of its shares.
Eroding Analytics Drop Sanofi (SNY) to Buy
Sanofi SA (NYSE:SNY) is one of 133 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 783 company GICS Health…
Prepare to Profit with Johnson & Johnson (JNJ) Earnings
Johnson & Johnson earnings are just around the corner. Here’s what the market is expecting for JNJ stock and how to profit from the event.
Sanofi (SNY) Earnings Growth Hurt Rating
Portfolio Grader currently ranks Sanofi SA (NYSE:SNY) a Hold. The system for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks…
Sanofi (SNY) Shares a Buy on Earnings Momentum
Sanofi SA (NYSE:SNY) is a constituent of the 133 company Pharmaceuticals GICS industry group, which is part of the 785 company GICS Health Care sector.…
Johnson & Johnson (JNJ) Stock Breaks Higher
Johnson & Johnson (NYSE:JNJ) is rising up and over its four-month trading range to return to levels not seen since November.
Sanofi (SNY) a Hold on Vapid Earnings Momentum
Sanofi SA (NYSE:SNY) is a constituent of the 134 company Pharmaceuticals GICS industry group, which is a segment of the 782 company GICS Health Care…
Trade of the Day: Johnson Controls International (JCI)
We’re likely to see some further downside action until at least the end of September, so I’m now firmly in the bearish camp.
At $128.22, Johnson & Johnson (JNJ) a Sell
At $128.22, Johnson & Johnson (JNJ) is a Sell based on the latest market intelligence, and relative pricing of its shares.
7 – 10 of 240 results
